A worm-like nucleic acid nanostructure for gene delivery and endosomal escape via ClC3 ion exchanger
- Sci Adv. 2026 Mar 6;12(10):eadw0891. doi: 10.1126/sciadv.adw0891.
- 1. Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
- 2. Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
- 3. Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
- 4. School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
- 5. School of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
- 6. School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
- 7. Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park, Shatin, New Territories, Hong Kong SAR.
Nanoparticle-based gene delivery can enable therapeutic applications with lower cytotoxicity than viral vectors, but its efficacy is often hampered by endosomal entrapment. We present a nucleic acid nanotechnology approach to circumvent this delivery bottleneck by adsorbing therapeutic nucleic acids (DNA, small interfering RNA, MicroRNA, or messenger RNA) to a gold-polydopamine nanoworm template, thereby assembling a three-dimensional worm-like nucleic acid nanostructure. Devoid of cationic groups, lipids, or mechanical stimuli, this nanostructure naturally activates the chloride voltage-gated channel 3 (ClC3) ion exchanger in endosomes given its worm-like shape; in turn, ClC3 mediates endosomal H+ and Cl- accumulation and eventual membrane rupture for cytosolic release, contributing to robust endosomal escape with a correlation coefficient <0.2 between the nanostructure and endosomes. We showcase in vitro gene regulation for primary macrophage polarization and mesenchymal stromal cell differentiation, ex vivo programmable mesenchymal stromal cell-based therapy for kidney fibrosis, and in vivo hepatocyte delivery for treating liver injury. Our versatile nucleic acid nanostructure will empower safe and effective gene therapies.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
-
Research Areas: Inflammation/Immunology
-
-
Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
-